关于：彼得·布洛尔最近对格拉司琼的综述。 - Suppr

Re: Peter Blower's recent review of granisetron.

作者信息

Russo Mark

出版信息

Support Care Cancer. 2004 Jan;12(1):64-5; author reply 66-8. doi: 10.1007/s00520-003-0545-6. Epub 2003 Dec 12.

DOI:10.1007/s00520-003-0545-6

PMID:14673627

Abstract

摘要

相似文献

Re: Peter Blower's recent review of granisetron.

Support Care Cancer. 2004 Jan;12(1):64-5; author reply 66-8. doi: 10.1007/s00520-003-0545-6. Epub 2003 Dec 12.

Granisetron: relating pharmacology to clinical efficacy.

Support Care Cancer. 2003 Feb;11(2):93-100. doi: 10.1007/s00520-002-0410-z. Epub 2002 Nov 15.

Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies.

Support Care Cancer. 2005 Sep;13(9):671-8. doi: 10.1007/s00520-004-0766-3. Epub 2005 Jul 26.

The efficacy of granisetron for cancer patients undergoing platinum-based chemotherapy: comparison of 1 miligram versus 3 miligram doses in preventing nausea and vomiting.

Acta Med Indones. 2005 Oct-Dec;37(4):210-3.

Granisetron transdermal system: a new option to help prevent chemotherapy-induced nausea and vomiting.

Clin J Oncol Nurs. 2009 Dec;13(6):711-4. doi: 10.1188/09.CJON.711-714.

Granisetron and ondansetron for chemotherapy-related nausea and vomiting.

Haematologia (Budap). 1998;29(1):25-31.

[The use of granisetron per os in radiotherapy-induced emesis].

Minerva Med. 1996 Dec;87(12):605-8.

Efficacy of two oral dose regimens of granisetron.

Anticancer Res. 1995 Sep-Oct;15(5B):2287-90.

Granisetron-dexamethasone combination for multiple day cisplatin.

Anticancer Res. 1995 Sep-Oct;15(5B):2261-3.

A granisetron patch (sancuso).

Med Lett Drugs Ther. 2008;50(1301-1302):103-4; quiz p 2 following 104.

本文引用的文献

Granisetron: relating pharmacology to clinical efficacy.

Support Care Cancer. 2003 Feb;11(2):93-100. doi: 10.1007/s00520-002-0410-z. Epub 2002 Nov 15.

The cardiotoxic potential of the 5-HT(3) receptor antagonist antiemetics: is there cause for concern?

Oncologist. 2002;7(1):65-72. doi: 10.1634/theoncologist.7-1-65.

Heterogeneity in systemic availability of ondansetron and granisetron following oral administration.

Drug Metab Dispos. 1999 Jan;27(1):110-2.

5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.

Drugs. 1998 Feb;55(2):173-89. doi: 10.2165/00003495-199855020-00002.

Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.

J Clin Oncol. 1998 Feb;16(2):754-60. doi: 10.1200/JCO.1998.16.2.754.

5-HT3 receptor antagonists: differences and similarities.

Eur J Cancer. 1997 Aug;33(9):1364-70. doi: 10.1016/s0959-8049(97)00003-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Re: Peter Blower's recent review of granisetron.

作者信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献